We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Alpine Immune Sciences Inc | NASDAQ:ALPN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 64.97 | 68.23 | 61.74 | 0 | 01:00:00 |
NEW YORK, April 11, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
Alpine Immune Sciences, Inc. has agreed to be acquired by Vertex Pharmaceuticals Incorporated. Under the proposed transaction, Alpine shareholders will receive $65.00 per share.
JBT Corporation entered into a merger agreement with Marel hf. Shareholders of Marel will have the option to receive either €3.60 per share in cash, all in JBT common stock for 0.0407 per share, or a combination of cash and JBT for €1.26 in cash and 0.0265 JBT shares.
Eliem Therapeutics, Inc. has entered into an agreement to acquire Tenet Medicines Inc., under which Tenet's shareholders will be compensated with new shares representing 15.4% of Eliem's common stock following the transaction's closure.
HireRight Holdings Corporation has agreed to merge with affiliates of General Atlantic, L.P. and Stope Point Capital LLC for $14.35 per share in cash.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-alpn-jbt-elym-and-hrt-investors-to-contact-law-firm-302114662.html
SOURCE Kuehn Law, PLLC
Copyright 2024 PR Newswire
1 Year Alpine Immune Sciences Chart |
1 Month Alpine Immune Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions